Guardant Health Quarterly Cash Flow Statement
NASDAQ: GHHealth CareMedical SpecialitiesUSD
167.47+1.91 (+1.15%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Guardant Health free cash flow
In the quarter ended Jun 30, 2026, Guardant Health generated -$57.8 million of operating cash flow and spent $11.8 million on capital expenditures. That left free cash flow of -$69.5 million, a free-cash-flow margin of -20.8% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Guardant Health cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -120.14M | -112.08M | -128.49M | -92.72M | -99.90M | -95.16M | -111.01M | -107.75M | -102.63M | -114.98M | -187.04M | -86.10M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 9.56M | 9.44M | 10.05M | 9.41M | 10.04M | 10.24M | 10.45M | 10.60M | 10.62M | 10.71M | 10.87M | 11.04M |
| Stock-Based Compensation | 57.73M | 47.61M | 43.19M | 42.81M | 42.46M | 37.76M | 36.37M | 49.77M | 27.23M | 27.04M | 24.32M | 21.82M |
| Change in Working Capital | -32.33M | 800.00K | -14.21M | 4.11M | -4.04M | -9.16M | -12.24M | 2.45M | -13.54M | 9.09M | 12.69M | -9.04M |
| Operating Cash Flow | -57.78M | -65.62M | -26.37M | -35.41M | -60.28M | -62.69M | -64.51M | -51.06M | -94.00M | -30.28M | -78.73M | -77.79M |
| Capital Expenditures | -11.76M | -5.58M | -27.85M | -10.35M | -5.65M | -4.46M | -18.88M | -4.20M | -5.08M | -6.93M | -4.08M | -2.37M |
| Investing Cash Flow | 101.47M | 699.42M | -905.07M | -14.35M | -10.65M | 302.86M | 10.53M | -294.83M | -5.08M | 28.07M | 663.45M | 260.70M |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | -45.01M | 0 | 0 | 0 | 0 | — | — |
| Financing Cash Flow | 23.01M | -21.58M | 732.03M | 4.33M | 1.62M | -66.85M | -2.94M | -2.88M | 5.90M | -1.07M | 90.57M | 3.81M |
| Net Change in Cash | 66.30M | 612.02M | -200.10M | -45.97M | -68.37M | 174.10M | -58.61M | -346.87M | -94.02M | -4.43M | 676.32M | 186.19M |
| Free Cash Flow | -69.54M | -71.20M | -54.22M | -45.76M | -65.93M | -67.15M | -83.39M | -55.26M | -99.08M | -37.22M | -82.81M | -80.16M |
This table shows 12 quarterly periods of Guardant Health's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow GH's reporting calendar. What is a cash flow statement?